MedTrace Logo

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

NCT04684602 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2022-04-29

No results posted yet for this study

Summary

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Conditions

Interventions

BIOLOGICAL

PrimePro™/ PrimeMSK™

Injection via condition specific route of administration.

Sponsors & Collaborators

  • HeartStem Institute

    collaborator UNKNOWN

  • NuStem

    collaborator UNKNOWN

  • Thomas Advanced Medical LLC

    lead INDUSTRY

Principal Investigators

  • Ernst R Von Schwarz, MD, PhD · HeartStem Institute, Southern California Hospital at Culver City

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-09
Primary Completion
2030-07-09
Completion
2030-12-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04684602 on ClinicalTrials.gov